Bio­phar­ma com­pa­nies, BAR­DA call for more clar­i­ty on FDA's new plat­form tech pro­pos­al

Fol­low­ing the FDA’s May re­lease of long-await­ed draft guid­ance ex­plain­ing how com­pa­nies can win des­ig­na­tions for cer­tain cell and gene ther­a­py “plat­form” tech­nolo­gies, com­pa­nies like …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER